Pharmafile Logo
Pharmafocus logo
Advanced Search

diabetes

Showing 15 posts of 391 posts found.

Boehringer and Vitae Pharma drug fails in mid-stage trial

July 1, 2015
Research and Development BI, Boehringer, Boehringer Ingelheim, Vitae Pharmaceuticals, diabetes, type 2 diabetes

A pipeline diabetes drug co-developed by Vitae Pharma and German giants Boehringer Ingelheim has failed to show benefits in a …

News
Januvia image

Merck diabetes drug gets CV trial boost

June 9, 2015
Research and Development, Sales and Marketing Januvia, Merck, cv, diabetes, sitagliptin

Merck’s diabetes drug Januvia has been given a boost following worries over side effects for patients after a trial revealed …

News
Novo image

Novo Nordisk launches diabetes combination

June 8, 2015
Sales and Marketing Novo Nordisk, Xutolphy, ada, diabetes

Diabetes specialist firm Novo Nordisk has launched a new treatment in the UK which combines two of the Danish firm’s …

News
Astrazeneca image

AstraZeneca makes a move into precision medicine

May 13, 2015
Research and Development, Sales and Marketing AstraZeneca, Precision Medicine, cardiovascular diseases, diabetes, mhi

AstraZeneca has signalled its intention to ramp up the use of personalised medicine strategies to find new candidate drugs and …

News
Novo image

Novo Nordisk invests in haemophilia with Denmark facility

May 5, 2015
Manufacturing and Production, Sales and Marketing Novo Nordisk, diabetes, haemophilia, novoseven

Novo Nordisk is spending around $225 million on a new facility in Kalundborg, Denmark to produce active pharmaceutical ingredients for haemophilia …

News
FDA image

AZ and Takeda diabetes drugs get FDA safety update

April 15, 2015
Manufacturing and Production, Sales and Marketing AstraZeneca, FDA, Nesina, Onglyza, Takeda, alogliptin, cardiovascular, diabetes, saxagliptin

An FDA advisory committee has said that the labels of two type 2 diabetes drugs should be changed to warn …

News
Astrazeneca image

AstraZeneca partners with PatientsLikeMe

April 14, 2015
Sales and Marketing AstraZeneca, Lupus, PatientsLikeMe, Roche, diabetes, oncology, respiratory disease

AstraZeneca has signed a five-year agreement with PatientsLikeMe to give the pharma firm access to the latter’s global network of …

News
Novo image

Novo Nordisk opens insulin plant in Russia

April 10, 2015
Manufacturing and Production, Sales and Marketing Novo Nordisk, Russia, diabetes, flexpen, insulin, kaluga, penfill

Denmark’s Novo Nordisk has opened a new manufacturing facility in Russia to produce more of its diabetes offerings in the …

News
Novo image

FDA to look again at Novo Nordisk insulin submissions

April 8, 2015
Research and Development, Sales and Marketing Novo Nordisk, Ryzodeg, Tresiba, diabetes, insulin degludec

Diabetes specialist firm Novo Nordisk has resubmitted its applications for two insulins to the FDA, along with new interim safety …

News
Actos image

Takeda offers $2.2 billion to resolve Actos damages claims

April 1, 2015
Sales and Marketing Actos, Cancer, Takeda, bladder, diabetes, heart, pioglitazone

Takeda has attempted to settle its hefty damages bill over claims it was hiding cancer risks in its diabetes drug …

News
Novo image

Novo resubmits FDA application for two diabetes drugs

March 27, 2015
Sales and Marketing Danish, FDA, Novo Nordisk, Ryzodeg, Tresiba, diabetes

Novo Nordisk will re-submit an FDA application for its diabetes drugs Tresiba and Ryzodeg two years after their initial rejection …

News
Astrazeneca image

AstraZeneca and Harvard team up for diabetes research

March 25, 2015
Research and Development, Sales and Marketing AZ, AstraZeneca, Havard, cardiovascular, diabetes, metabolic

AstraZeneca is to work with Harvard University’s department of stem cell and regenerative biology to develop new treatments in diabetes. …

News

Lilly and Boehringer diabetes drug sees US launch

March 24, 2015
Sales and Marketing Boehringer, Glyxambi, Tradjenta, diabetes, empagliflozin/linagliptin, lilly, linagliptin

Lilly and Boehringer Ingelheim’s combo diabetes drug Glyxambi is now available to treat adult patients in the US. Glyxambi (empagliflozin/linagliptin) …

News
Sanofi image

Type 1 diabetes market value to double by 2023

March 19, 2015
Research and Development, Sales and Marketing GlobalData, NHS, NICE, Sanofi, diabetes, toujeo, type 1

The treatment market for type 1 diabetes is set to double to around $13.6 billion by 2023 according to analysts …

News
Sanofi image

Sanofi diabetes drug fails to show cardio disease benefit

March 19, 2015
Research and Development, Sales and Marketing ACS, Lixisenatide, Lyxumia, Sanofi, cardio, diabetes

A Phase IIIb study of Sanofi’s diabetes drug lixisenatide has shown it is no better or worse than a placebo …

News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026